SPECT-CT
SPECT-CT is an intervention with 15 clinical trials. Currently 2 active trials ongoing. Historical success rate of 85.7%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
75.0%
6 of 8 finished
25.0%
2 ended early
2
trials recruiting
15
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
SPECT-CT vs MRI for the Diagnosis of Osteoarthritis in the Foot and Ankle
Study of Lymphatic Drainage Mapping in Oropharyngeal Cancers
Role of SPECT/CT of Bone Scan in Charactarization of Bone Lesions
A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent
Use of SPECT-CT for Comparison of Dosimetry Methods in PSMA-targeted Radioligand Therapy (SPECTacular Study)
Clinical Trials (15)
SPECT-CT vs MRI for the Diagnosis of Osteoarthritis in the Foot and Ankle
Study of Lymphatic Drainage Mapping in Oropharyngeal Cancers
Role of SPECT/CT of Bone Scan in Charactarization of Bone Lesions
A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent
Use of SPECT-CT for Comparison of Dosimetry Methods in PSMA-targeted Radioligand Therapy (SPECTacular Study)
Evaluation of Ventilation Homogeneity as a Marker of Small Airway Disease in Active Smokers
Intraoperative Dual-modality Imaging in Renal Cell Carcinoma
Detection and Localization of Carcinoma Using High Resolution Transrectal Imaging - Proof of Concept Study
SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy
The Role of Tc 99m MDP SPECT/CT in Osteoarthritis
Diagnostic Imaging of Bone Metastases in Prostate Cancer Patients
Feasibility Study to Develop Sentinel Lymph Node Mapping in Rectal Cancer Patients
99mTc-MIBI SPECT/CT in Breast Malignancy
123I-MIBG SPECT/CT for Assessment of Cardiac Sympathetic Innervation
SPECT/CT in Endocrine and Neuroendocrine Tumors
All 15 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 15